The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Cerner Corp

Nasdaq: CERN
Last

(U.S.) $72.06

Today's change-0.72 -0.98%
Updated February 27 4:00 PM EST. Delayed by at least 15 minutes.
 

Cerner Corp

Nasdaq: CERN
Last

(U.S.) $72.06

Today's change-0.72 -0.98%
Updated February 27 4:00 PM EST. Delayed by at least 15 minutes.

Cerner Corp down (U.S.)$0.72

Cerner Corp closed lower Friday, dropping (U.S.)$0.72 or 0.98% to (U.S.)$72.06. Over the last five days, shares are unchanged, but are currently 1.61% below its 52-week high. This security has outperformed the S&P 500 by 4.23% during the last year.

Key company metrics

  • Open(U.S.) $72.43
  • Previous close(U.S.) $72.78
  • High(U.S.) $72.75
  • Low(U.S.) $72.02
  • Bid / Ask-- / --
  • YTD % change+11.44%
  • Volume1,199,129
  • Average volume (10-day)1,598,782
  • Average volume (1-month)1,769,178
  • Average volume (3-month)1,355,676
  • 52-week range(U.S.) $48.39 to (U.S.) $73.24
  • Beta0.56
  • Trailing P/E48.05×
  • P/E 1 year forward34.09×
  • Forward PEG1.59×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.50
Updated February 27 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+15.44%

Based on its net profit margin of 15.44%, Cerner Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJan 03, 201501/03/2015Sep 27, 201409/27/2014Jun 28, 201406/28/2014Mar 29, 201403/29/2014
Revenue926840852785
Total other revenue--------
Total revenue926840852785
Gross profit753700689656
Total cost of revenue173140162129
Total operating expense721652660607
Selling / general / administrative441415400386
Research & development79727266
Depreciation / amortization28252525
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income205188192178
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax208190194181
Income after tax148129129120
Income tax, total61616561
Net income148129129120
Total adjustments to net income--------
Net income before extra. items148129129120
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items148129129120
Inc. avail. to common incl. extra. items148129129120
Diluted net income148129129120
Dilution adjustment------0
Diluted weighted average shares350349350352
Diluted EPS excluding extraordinary itemsvalue per share0.420.370.370.34
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.420.370.370.34